-
Mashup Score: 3
An abstract is unavailable.
Source: journals.lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Chuck - Renal Cell Carcinoma - 1 year(s) ago
Facing an Unexpected Challenge Renal Cell Carcinoma Chuck’s Story Chuck is a self-professed type A personality. An ‘Irish Catholic kid from Boston,’ he reached the top of the corporate ladder in a demanding position as Vice President of Business Operations with the National Fire Protection Association. Naturally, he…
Source: CRISPRCategories: Future of Medicine, Latest HeadlinesTweet-
Meet Chuck, a Boston native and incredible advocate living with #renalcellcarcinoma. Read his inspiring story here: https://t.co/XBR2pOWlNp #kidneycancers https://t.co/Oy96iSpnQ4
-
-
Mashup Score: 0
Nivolumab/ipilimumab achieves 1-year PFS of 100% in unresectable T1N0M0 tumors
Source: www.medpagetoday.comCategories: Latest Headlines, Oncologists2Tweet-
Unresectable nonmetastatic #kidneycancers regressed substantially, but not completely, in response to treatment with nivolumab (Opdivo) and ipilimumab (Yervoy), said Ilya Tsimafeyeu, MD, of the Kidney Cancer Research Bureau, during #IKCSNA22. https://t.co/MZVP9N2dM5 #OncTwitter
-
-
Mashup Score: 8Mayo Clinic Q&A podcast: Kidney cancer often found by accident - 3 year(s) ago
Your kidneys remove waste from your blood and regulate a healthy balance between water, sodium and minerals in your bloodstream. […]
Categories: General Medicine Journals and Societies, Latest HeadlinesTweet-
In this #MayoClinicQandA podcast, Dr. Cheney discusses different types of #kidneycancers, how smoking can affect the kidneys and why treatment usually involves surgery. https://t.co/yPMbWgNLsC @hmgazelkamd
-
-
Mashup Score: 0Immunotherapy Plus TKI Regimens Appear Promising for Patients With Renal Cell Carcinoma - 3 year(s) ago
In an interview with Targeted Oncology, Chung-Han (Joe) Lee, MD, PhD, discussed the use of different targeted therapy and immunotherapy strategies for the treatment of patients with metastatic kidney cancer.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
"...what we don't have, despite the outstanding efficacy of these combinations in the first-line setting, is prospective data about regimens after people have progression on immune checkpoint inhibitors," said Dr. Lee. https://t.co/cTQAT6Qo5g #kidneycancers
-
-
Mashup Score: 0The genomic and epigenomic evolutionary history of papillary renal cell carcinomas - PubMed - 4 year(s) ago
Intratumor heterogeneity (ITH) and tumor evolution have been well described for clear cell renal cell carcinomas (ccRCC), but they are less studied for other kidney cancer subtypes. Here we investigate ITH and clonal evolution of papillary renal cell carcinoma (pRCC) and rarer kidney cancer subtypes …
Source: PubMedCategories: Genetics, Latest HeadlinesTweet-
Integrative genomic and epigenomic analysis in @NatureComms on the intratumor heretogeneity of rare #KidneyCancers provide new insights into the clonal evolution of these subtypes. #NCI_ITEB https://t.co/iUFF8F5AYx
-
Researchers used CRISPR/Cas9 gene editing to create a model that faithfully represents RCC in humans and introduced specific mutations that closely mimic the early stages of human #kidneycancers to see how tumors evolve and #metastasize. https://t.co/1ebCQxdFhS https://t.co/7FrtBen3oG